Cholesterol Will Be Reduced In A Week: Patanjali Drugs Banned In Uttarakhand, Misleading Advertisement: Uttarakhand has banned the production of five Patanjali medicines for misleading advertising. The action belongs to the Ayurveda Unani Licensing Authority of Uttarakhand.
Divya Pharmacy, owned by Baba Ramdev, has been ordered to stop the production of five medicines under the Patanjali brand. Madhugrit, Igrit, Thyrogrit, Bipigrit, and Lipidom are medicines for high blood pressure, diabetes, glaucoma, goiter, and cholesterol.
Earlier, the AYUSH Ministry had found that the advertisement of the medicines ‘Lipidome’, ‘Livogrit’, and ‘Livamrit’ manufactured by Divya Pharmacy under Patanjali was misleading. It was also stated that this is a violation of the law.
The ‘Lipidome’ advertisement claimed to reduce cholesterol in a week. They used to advertise that heart-related diseases, stroke, and blood pressure will be cured soon. ‘Livogrit’ and ‘Livamrit’ were advertised as remedies for inflammation of the liver, liver cirrhosis, and other digestive problems.
The authority has asked Patanjali to submit revised formulation sheets and label applications for each drug if it wants to resume production.
However, the company’s explanation is that despite the issuance of the order signed by the licensing officer, the notification of the ban has not been received. The company also alleges that the anti-Ayurveda mafia is behind the campaign.
At the same time, Kannur’s ophthalmologist Dr. KV Babu had earlier filed a complaint with the Ayurveda Unani Licensing Authority and the Ministry of Ayush.
The Magic Remedies Act of 1940 and the Drugs and Cosmetics Act prohibit the advertising of medicines for these diseases. Kannur native eye specialist Dr. KV Babu filed a complaint with the Ayush Ministry and the Uttarakhand Ayurveda Unani Licensing Authority.
Due to this, the Drug Licensing Authority of Uttarakhand delayed the process despite the Ministry of AYUSH giving several notices. Five months have passed since the licensing authority of Uttarakhand has not responded to the AYUSH ministry’s notices citing the advertisements as misleading.
Finally, the Ministry of AYUSH also clarified that it has been instructed to take action as soon as possible and submit a report. Following this, the Licensing Authority took action by banning the production of Patanjali medicines.
Meanwhile, the AYUSH Ministry informed the Parliament in July that there has been a huge increase in the number of misleading advertisements. Between March 2021 and June 2022, 10,035 advertisements were reported. The complaint was against 6,804 advertisements between March 2020 and February 2021.
